Analyst Ratings for AstraZeneca PLC ADR (AZN)Updated: 2017-07-26
An average rating of Overweight has been given to AstraZeneca PLC ADR (NYSE:AZN) by analysts covering the stock. A consensus rating of Overweight was previously issued for AZN last month.
18 analysts declared AZN a buy, 2 gave an overweight rating, 14 gave a hold rating, 1 gave an underweight rating, and 4 gave a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has decreased by 2. Meanwhile, the number of analysts pessimistic about the company has increased by 0.
Investment analysts gave a few price targets for AZN. The most optimistic price target was 51.55, which equates to a potential upside of 52.74 percent. The minimum price target given was 25, implying a possible loss of -25.93 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.
Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of -5.73 percent. The average change in earnings estimates over the last 90 days is -4.6 percent. On the other hand, earnings estimates for the fiscal year have been revised downwards by -0.54 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 1.1 percent.
Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 2 analysts made negative revisions. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 3 analysts decreased their estimates.
The growth rate of AZN's earnings is estimated by analysts to be 50.63 percent. The PEG ratio of a stock is another value frequently studied by investors. Investors like to see smaller values for the PEG ratio, because that is often interpreted as the company being fairly priced relative to its growth rate. PEG ratios below 1 are often considered desirable, but many choose to perform ratio comparisons with other companies in the industry. AZN has a PEG ratio of 0.55.
AZN has a 52-week high of 35.60 and a 52-week low of 25.55. Currently the stock is 32.09 percent higher than its low, and 5.2 percent below the high. AZN has a price/earnings ratio of 27.61. Investors typically compare the P/E ratio to a company's peers in the industry. The AZN value stock report compares AZN to some of its peers using value stock charts. The market cap of AZN is $84.02 billion. AZN's next earnings release will be on 0000-00-00, which is days away.